Peptide pills for brain diseases? Reality and future perspectives.

about

Targeting prion protein interactions in cancer.Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.

P2860

Q36147332-ED589939-D0B8-44D8-9D80-512601E82620 Q51706707-173E2213-FA7B-43F3-AAA8-0F5171717021 Q54970083-7E3B8E63-EF47-4706-B023-7830444C3DB5

P2860

Peptide pills for brain diseases? Reality and future perspectives.

Item

http://www.wikidata.org/entity/Q38096036

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Peptide pills for brain diseases? Reality and future perspectives.

@en

type

Item

label

Peptide pills for brain diseases? Reality and future perspectives.

@en

prefLabel

Peptide pills for brain diseases? Reality and future perspectives.

@en

P1476

Peptide pills for brain diseases? Reality and future perspectives

@en

P2093

Dolores Remedios Serrano Lopez

http://www.w3.org/2001/XMLSchema#string

P2860

Zinedin, SG2NA, and striatin are calmodulin-binding, WD repeat proteins principally expressed in the brain

Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Striatin, a calmodulin-dependent scaffolding protein, directly binds caveolin-1

Fusion to snowdrop lectin magnifies the oral activity of insecticidal ω-Hexatoxin-Hv1a peptide by enabling its delivery to the central nervous system

Structure and function of the blood-brain barrier

Can the pharmaceutical industry reduce attrition rates?

The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.

Vitamin B12 as a carrier for the oral delivery of insulin.

P304

479-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE.13.5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dolores R Serrano

Katerina Lalatsa

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236112626

http://www.w3.org/2001/XMLSchema#string

P698

23557289

http://www.w3.org/2001/XMLSchema#string

Peptide pills for brain diseases? Reality and future perspectives.

about

P2860

P2860

Peptide pills for brain diseases? Reality and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698